Medical Services

Coastal Developmental Paediatrics is a medical administration company which supports specialist paediatric doctors by providing facilities and administration services for their practice. All of the doctors who attend this clinic are independent contractors and are solely responsible for the provision of medical services and advice for your child.

All Paediatricians at Coastal Developmental Paediatrics provide individualised, specialist assessment and management of childhood developmental and behavioural conditions. Some also provide care for non-acute medical issues in children and infants.

Each specialist paediatric doctor (consultant) has experience in the assessment and management of:

Please contact the friendly administration team if you wish to seek further information about services provided by one of the doctors.

If you wish to book an appointment please arrange a GP referral to be sent, named to one of the paediatricians via email (admin@cdpaediatrics.com.au) Medical-Objects or via fax to us. Please note: email correspondence including sensitive information sent to the practice may not be secure, unless emailed with encryption coding. Sensitive information sent via Medical-Objects direct referrals from GP's practices, or faxed referrals, is more secure.

AGE range for Paediatric services: The Paediatricians accept new referrals for children up to 12 years of age according to each doctor's availability (see "For referrers" section of website for updates on specific doctor availability and referral criteria). Some doctors will provide extended care for their existing, well-known older patients up to 16 -18 years of age, depending on the young person's issues. Paediatricians are required to then transition patients back to GP care before 18 years of age, for the GP to facilitate referral on to adult care services. Stimulant medication prescriptions from Paediatricians are not valid once the child turns 18 years.

RE: ONGOING INTERMITTENT SUPPLY INTERRUPTIONS OF Concerta (Methylphenidate hydrochloride XR), Ritalin and Ritalin LA and VYVANSE® (lisdexamfetamine dimesilate)

Instructions for families experiencing pharmacy shortages of Methylphenidate medications Concerta (Methylphenidate hydrochloride XR), Methylphenidate (Ritalin and Artage), and Ritalin LA and Vyvanse (Lisdexamfetamine), as per the current Australian Government TGA (medication authorisations body) website. Updates regarding the supply of these medications will now provided for pharmacists and Drs through the TGA website. Medication shortages are being created due to overseas manufacturing, supply and demand issues worldwide and affect Australians because most of our medications are now manufactured off-shore due to cheaper production costs.

Since 10 December 2024, there have been no reported supply shortages of Vyvanse (notification updated April 2025).

Pharmaceutical companies Janssen-Cilag and Teva Pharma have notified the TGA about the shortages of their methylphenidate hydrochloride modified-release tablet products Concerta and Teva-XR in December 2024, expected until 31 December 2025. 

In April 2025, the pharmaceutical company Novartis notified the TGA about delays to their upcoming order of immediate-release methylphenidate tablet products, Ritalin and Artige 10 mg.

They also anticipate shortages of their Ritalin LA (methylphenidate hydrochloride) modified-release capsule products. 

These shortages are due to manufacturing issues and are affecting multiple countries. To help with supply issues, the TGA have approved access to several overseas-registered strengths of Concerta modified-release tablets.

Please note that certain medicines a pharmacist can substitute may cost you more as they may be a more expensive brand which may not be subsidised fully by the PBS, and in some cases you may require a new prescription. The pharmacist will tell you about this.

Whilst some doses of Concerta and Methylphenidate-TEVA XR (generic brand version of Concerta) are reported to be intermittently unavailable between 1 December 2024 and 31 December 2025, other forms of methylphenidate medicines, such as immediate-release tablets and modified-release capsules (Ritalin LA), have remained available until April 2025. From April/ May through to 31 December 2025 the TGA website now advises that there will be intermittent shortages of other forms of Methylphenidate. 

Other medicines approved to treat ADHD such as Dexamfetamine and Vyvanse (Lisdexamfetamine slow-release) are still available. 

We urge patients who will be affected by these shortages to speak with their pharmacist about supply, including the option to be supplied with Methylphenidate-TEVA XR ARX (generic brand) or Concerta (Switzerland) with their existing Concerta script, and to call around alternative pharmacies for supply options. Doctors will endeavour to provide an alternative medication script if the supply shortage continues, however a consultation is needed (which can be telehealth) to provide any authorised medication script, as authority needs to be obtained for each script by the doctor via the PBS TGA which is time-consuming for the Dr.

Children can be provided an alternative script for the equivalent or lower dose of Methylphenidate MR - Ritalin LA (long-acting) by their Paediatrician or GP. This still contains Methylphenidate which is the active ingredient in Concerta, although the Ritalin LA has a different delivery system and shorter duration of action to Concerta. Ritalin LA lasts 6-8 hours duration and Concerta 8-10 hours. A top-up of morning or afternoon Methylphenidate IR (Ritalin immediate release) may be used to extend the time of duration across the day if the Ritalin LA morning dose is not active for long enough for the child's needs. 

Please contact administration if you require further assistance from your doctor with obtaining your child's Methylphenidate XR/ Concerta or other Methylphenidate medication.

If your Paediatrician is not available, please discuss this with your usual GP.

If you require any further information in relation to the structure of the Coastal Developmental Paediatrics company please contact:

Coastal Developmental Paediatrics Practice Manager: pm@cdpaediatrics.com.au

Beach Paed Pty Ltd Trading as Coastal Developmental Paediatrics

ABN 57 634 099 255